KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
3.320
-0.010 (-0.30%)
Aug 19, 2026, 4:00 PM EDT - Market closed
KORU Medical Systems Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, KORU Medical Systems stock has a consensus rating of "Strong Buy" and an average price target of $6.60. The average 1-year stock price forecast is 98.80% higher than the current stock price, while the lowest is $5.00 (+50.60%) and the highest is $8.00 (+140.96%).
Price Target: $6.60 (+98.80%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for KORU Medical Systems stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $6 | Buy | Reiterates | $6 | +80.72% | Aug 13, 2026 |
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Reiterates $8 | Buy | Reiterates | $8 | +140.96% | Aug 7, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $7 → $6 | Buy | Reiterates | $7 → $6 | +80.72% | Aug 6, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $5 | Hold | Reiterates | $5 | +50.60% | Aug 6, 2026 |
| Lake Street | Lake Street | Buy Reiterates $8 | Buy | Reiterates | $8 | +140.96% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
48.04M
from 41.13M
Increased by 16.82%
Revenue Next Year
56.18M
from 48.04M
Increased by 16.94%
EPS This Year
-0.01
from 0.01
EPS Next Year
0.04
from -0.01
EPS and Forward PE are based on non-GAAP adjusted numbers.